[1] HEKKING P P, WENER R R, AMELINK M, et al.The prevalence of severe refractory asthma[J].J Allergy Clin Immunol,2015,135(4):896-902.
[2] BARNES P J.Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J].J Allergy Clin Immunol,2013,131(3):636-645.
[3] CHUNG K F, WENZEL S E, BROZEK J L, et al.International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma[J].Eur Respir J,2014,43(2):343-373.
[4] YOO J, MEYERS J, REDDEL H.Difficult-to-treat and severe asthma in adults:Towards a new treatment paradigm[J].Aust J Gen Pract,2019,48(4):188-192.
[5] 中华医学会呼吸病学分会哮喘学组, 中国哮喘联盟.重症哮喘诊断与处理中国专家共识[J].中华结核和呼吸杂志, 2017,40(11):813-829.
[6] ROTH M, ZHAO F, ZHONG J, et al.Serum IgE induced airway smooth muscle cell remodeling is independent of allergens and is prevented by omalizumab[J].PLoS One,2015,10(9):e136549.
[7] FANG L, SUN Q, ROTH M.Immunologic and non-immunologic mechanisms leading to airway remodeling in asthma[J].Int J Mol Sci,2020,21(3):757.
[8] SAUNDERS R, KAUL H, BERAIR R, et al.DP(2) antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment[J].Sci Transl Med,2019,11(479).
[9] MATOBA A, MATSUYAMA N, SHIBATA S, et al.The free fatty acid receptor 1 promotes airway smooth muscle cell proliferation through MEK/ERK and PI3K/Akt signaling pathways[J].Am J Physiol Lung Cell Mol Physiol,2018,314(3):L333-L348.
[10] NAGASE H.Severe asthma in Japan[J].Allergol Int,2019,68(2):167-171.
[11] PAKHALE S, BARON J, DENT R, et al.Effects of weight loss on airway responsiveness in obese adults with asthma:does weight loss lead to reversibility of asthma?[J].Chest,2015,147(6):1582-1590.
[12] WANG K, LE CRAS T D, LARCOMBE A N, et al.Independent and combined effects of airway remodelling and allergy on airway responsiveness[J].Clin Sci (Lond),2018,132(3):327-338.
[13] DEL G S, BAKIRTAS A, BEL E, et al.Allergy in severe asthma[J].Allergy, 2017,72(2):207-220.
[14] PORSBJERG C, MENZIES-GOW A.Co-morbidities in severe asthma:Clinical impact and management[J].Respirology,2017,22(4):651-661.
[15] ATES F, VAEZI M F.Insight Into the Relationship Between Gastroesophageal Reflux Disease and Asthma[J].Gastroenterol Hepatol (N Y),2014,10(11):729-736.
[16] 王文雅, 林江涛, 周新, 等.我国>14岁重症哮喘患者的临床特征和患病危险因素[J].中华医学杂志, 2020(14):1106-1107.
[17] GUPTA S, SIDDIQUI S, HALDAR P, et al.Qualitative analysis of high-resolution CT scans in severe asthma[J].Chest,2009,136(6):1521-1528.
[18] KURT E, OZKAN R, ORMAN A, et al.Irreversiblity of remodeled features on high-resolution computerized tomography scans of asthmatic patients on conventional therapy:a 6-year longitudinal study[J].J Asthma,2009,46(3):300-307.
[19] SVENNINGSEN S, EDDY R L, LIM H F, et al.Sputum eosinophilia and magnetic resonance imaging ventilation heterogeneity in severe asthma[J].Am J Respir Crit Care Med,2018,197(7):876-884.
[20] SVENNINGSEN S, KIRBY M, STARR D, et al.What are ventilation defects in asthma?[J].Thorax,2014,69(1):63-71.
[21] FEROLDI F, WILLEMSE J, DAVIDOIU V, et al.In vivo multifunctional optical coherence tomography at the periphery of the lungs[J].Biomed Opt Express,2019,10(6):3070-3091.
[22] GOORSENBERG A.Bronchial thermoplasty-induced acute airway effects assessed with optical coherence tomography in severe asthma[J].Respiration,2018,96(6):564-570.
[23] ADAMS D C, MILLER A J, APPLEGATE M B, et al.Quantitative assessment of airway remodelling and response to allergen in asthma[J].Respirology,2019,24(11):1073-1080.
[24] SOJA J, GRZANKA P, SLADEK K, et al.The use of endobronchial ultrasonography in assessment of bronchial wall remodeling in patients with asthma[J].Chest,2009,136(3):797-804.
[25] KITA T, FUJIMURA M, KURIMOTO N, et al.Airway wall structure assessed by endobronchial ultrasonography and bronchial hyperresponsiveness in patients with asthma[J].J Bronchol Interv Pulmonol,2010,17(4):301-306.
[26] 刘心瑒, 宋小莲.共聚焦显微内镜在呼吸系统疾病中的应用进展[J].中华结核和呼吸杂志, 2019,42(2):125-128.
[27] GOORSENBERG A, KALVERDA K A, ANNEMA J, et al.Advances in optical coherence tomography and confocal laser endomicroscopy in pulmonary diseases[J].Respiration,2020,99(3):190-205.
[28] YICK C Y, VON DER TH?SEN J H, BEL E H, et al.In vivo imaging of the airway wall in asthma:fibered confocal fluorescence microscopy in relation to histology and lung function[J].Respir Res,2011,12(1):85.
[29] ZASTRZEZ.YŽSKA W, PRZYBYSZOWSKI M, BAZAN-SOCHA S, et al.Omalizumab may decrease the thickness of the reticular basement membrane and fibronectin deposit in the bronchial mucosa of severe allergic asthmatics[J].J Asthma,2020,57(5):468-477.
[30] HOSHINO M, OHTAWA J.Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma[J].Respiration,2012,83(6):520-528.
[31] TAJIRI T, NIIMI A, MATSUMOTO H, et al.Comprehensive efficacy of omalizumab for severe refractory asthma:a time-series observational study[J].Ann Allergy Asthma Immunol,2014,113(4):470-475.
[32] MOLIMARD M, MALA L, BOURDEIX I, et al.Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control[J].Respir Med,2014,108(4):571-576.
[33] MAURI P, RICCIO A M, ROSSI R, et al.Proteomics of bronchial biopsies:galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients[J].Immunol Lett,2014,162(1 Pt A):2-10.
[34] RICCIO A M, MAURI P, DE FERRARI L, et al.Galectin-3:an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months[J].Clin Transl Allergy,2017,7:6.
[35] HALDAR P, BRIGHTLING C E, HARGADON B, et al.Mepolizumab and exacerbations of refractory eosinophilic asthma[J].N Engl J Med,2009,360(10):973-984.
[36] ORTEGA H G, LIU M C, PAVORD I D, et al.Mepolizumab treatment in patients with severe eosinophilic asthma[J].N Engl J Med,2014,371(13):1198-1207.
[37] CHACHI L, DIVER S, KAUL H, et al.Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma[J].Eur Respir J,2019,54(5):1900930.
[38] NEMETH K, KEANE-MYERS A, BROWN J M, et al.Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma[J].Proc Natl Acad Sci U S A,2010,107(12):5652-5657.
[39] 姜艳山, 周敏, 瞿介明.难治性哮喘及其评估新技术研究进展[J].国际呼吸杂志, 2017,37(23):1819-1823.
[40] Mainardi A S, Castro M, Chupp G.Bronchial Thermoplasty[J].Clin Chest Med,2019,40(1):193-207.
[41] 蔡绍曦, 赵海金.重症哮喘的个体化治疗现状和展望[J].中华结核和呼吸杂志, 2017,40(11):806-808.
2021, Vol. 38 
